A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9
BioNTech SE
BioNTech SE
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Cedars-Sinai Medical Center
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
DualityBio Inc.
Big Ten Cancer Research Consortium
University of Nebraska
Genfit
RenJi Hospital